Michael Klichinsky, PharmD, PhD
Co-Founder, Vice President, Carisma Therapeutics
Hans Klingemann, MD, PhD
Vice President, NantKwest, Inc.
Mark Lowdell, PhD
Director, Centre for Cell, Gene & Tissue Therapeutics, RFH; Professor, University College London
Shiladitya Sengupta, PhD
Principle Investigator, Harvard Medical School and Massachusetts Institute of Technology
RJ Tesi, MD
CEO, CMO, INmune Bio
Bob Valamehr, PhD
MBA, Chief Development Officer, Fate Therapeutics, Inc.